CZCheng Zhang

Cheng Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cheng Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Jian Zhang

    Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    3 shared publications
  • Tingbo Liang

    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

    3 shared publications
  • Tao Wei

    Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

    2 shared publications
  • Yun Zhang

    Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    2 shared publications
  • Jianhui Zhao

    Department of Big Data in Health Science School of Public Health, Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    1 shared publication
  • Jin Li

    Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

    1 shared publication

Latest Publications

  • A novel clinical data management platform for acute pancreatitis

    by Shiyin Chen, Cheng Zhang, Zhi’en Wang, Jian Zhang, Wenqiao Yu, Yanshuai Wang, Weiwei Si, Tingbo Liang, Yun Zhang

    摘要 急性胰腺炎是一种常见的消化系统疾病, 其中重症急性胰腺炎治疗难度大且死亡率高, 尚需进行大量临床研究. 急性胰腺炎的诊治过程会产生大量的临床数据, 而不同医疗中心的数据存在很大的异质性, 这增加了临床研究的难度. 因此, 一个能够对真实世界数据实施结构化统一管理的单病种多中心数据平台将会成为一个提升急性胰腺炎相关临床研究的质量及进度的理想工具. 该平台包含以下内容: 临床数据的前结构化设定、 数据录入/导入方式的设定、 基于特征标记的同质病例检索功能、 以诊治场景重现为特征的数据输出模式、 数据安全及脱敏方式的设定、 数据共享及利用方式的设定、 随机对照试验 (RCT) 模块的搭载等. 急性胰腺炎多中心临床数据管理平台的使用让医疗中心在急性胰腺炎的诊治和研究中获得了安全精准、 结构统一、 追溯可行、 场景清晰、 功能齐全的真实世界医疗数据, 并且在开展多中心、 高质量、 多任务的临床研究的同时, 实现了临床诊治及医师培训质量的提升.


  • Top Cited Papers
    Open Access

    Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2

    by Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang, et al.

    The gut microbiota and liver cancer have a complex interaction. However, the role of gut microbiome in liver tumor initiation remains unknown. Herein, liver cancer was induced using hydrodynamic transfection of oncogenes to explore liver tumorigenesis in mice. Gut microbiota depletion promoted liver tumorigenesis but not progression. Elevated sterol regulatory element-binding protein 2 (SREBP2) was observed in mice with gut flora disequilibrium. Pharmacological inhibition of SREBP2 or Srebf2 RNA interference attenuated mouse liver cancer initiation under gut flora disequilibrium. Furthermore, gut microbiota depletion impaired gut tryptophan metabolism to activate aryl hydrocarbon receptor (AhR). AhR agonist Ficz inhibited SREBP2 posttranslationally and reversed the tumorigenesis in mice. And, AhR knockout mice recapitulated the accelerated liver tumorigenesis. Supplementation with Lactobacillus reuteri , which produces tryptophan metabolites, inhibited SREBP2 expression and tumorigenesis in mice with gut flora disequilibrium. Thus, gut flora disequilibrium promotes liver cancer initiation by modulating tryptophan metabolism and up-regulating SREBP2.


  • Effects of Short‐Peptide‐Based Enteral Nutrition on the Intestinal Microcirculation and Mucosal Barrier in Mice with Severe Acute Pancreatitis

    by Jian Zhang, Wen‐Qiao Yu, Tao Wei, Cheng Zhang, Liang Wen, Qi Chen, Wei Chen, Jun‐Yu Qiu, Yun Zhang, Ting‐Bo Liang

    Scope: Short‐peptide‐based enteral nutrition (SPEN) is absorbed more efficiently in patients with severe acute pancreatitis (SAP). More importantly, SPEN decreases SAP‐induced enterogenous infection risk. This study aims to investigate whether SPEN alleviates intestinal bacterial translocation in mice with SAP, and the underlying mechanisms.Methods and results: The SAP model is established after pre‐treatment with SPEN or intact‐protein‐based enteral nutrition. Although there is no improvement in pancreas injury, as evaluated through Hematoxylin‐Eosin staining or serum amylase, SPEN obviously attenuates intestinal bacterial translocation after SAP. To unveil the mechanisms, it is found that the intestinal mechanical barrier destroyed by SAP is significantly relieved by SPEN, which presents with recovered ZO‐1 expression, mucus layer, and goblet cell function. Additionally, SPEN alleviates local CCR6/CCL20 induced CD11c+ dendritic cell infiltration, systemic immunosuppression, and inhibits the secretion of luminal secretory immunoglobulin A. Possibly responsible for SAP‐induced mucosal dysfunctions, destroyed intestinal mucosal microcirculation and local hypoxia are largely improved in SAP+SPEN group.Conclusion: SPEN can improve downregulated intestinal mucosal microcirculation secondary to SAP, which may be responsible for mucosal inflammation relief, maintenance of the mechanical barrier and mucosal immunity, the correction of systemic immunosuppression, and play a protective role in defending commensal bacterial translocation after SAP.